Last reviewed · How we verify
NCT05651464: IPANEMA-ECMO
Impact of Prophylactic Antibiotics on Bloodstream Infections After Liberation From Extracorporeal Membrane Oxygenation
NA trial testing Vancomycine in Catheter-Related Infections in 42 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Universität des Saarlandes |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 42 |
| Start date | 1 January 2023 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Vancomycine — full drug profile →
Conditions studied
- Catheter-Related Infections — all drugs for Catheter-Related Infections →
Sponsor
Universität des Saarlandes — full company profile →
Who can join
18 and older, any sex, with Catheter-Related Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this prospective interventional study is to evaluate the impact of antibiotic prophylaxis on bloodstream infections after liberation of extracorporeal membrane oxygenation therapy. The main questions aims to answer are: • does application of vancomycine prior to ECMO liberation have an impact of bloodstream infections? Participants will get 1 dose of vancomycine I.V. (15-20 mg per kgKG) prior to liberation of ECMO. Researchers will compare this interventional group to a group without antibiotic prophylaxis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05651464
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Catheter-Related Infections
Currently open trials in the same condition.
- NCT07175116 — Advanced Dressings for CVC Infection Prevention in PICU · NA · recruiting
- NCT06905119 — Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience · NA · recruiting
Other Universität des Saarlandes trials
Trials by the same sponsor.
- NCT07530809 — Time-restricted Feeding in MASLD · NA · recruiting
- NCT06865950 — Sex diffErences in prehoSpitAl Stroke MEdicine · recruiting
- NCT06907563 — Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study) · not yet recruiting
- NCT06453577 — Pharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart Failure · active not recruiting
- NCT06459115 — Adherence to Medication in Patients With Acute Decompensated Heart Failure · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05651464 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universität des Saarlandes
- Last refreshed: 15 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05651464.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing